Clinical Trial Update: Rho Kinase in Patients With Atherosclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a Rho kinase-targeted therapy for atherosclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED